CXCR1 and breast carcinoma: Here, CXCR1 blockade by reparixin has shown promising activity against breast cancer in mouse xenografts models32 and CXCR1/2 inhibition by SCH-527123 did reduce tumour growth and microvessel density in a xenograft model of colorectal cancer33.